SPONSORED FEATURE: VARIAN MEDICAL SYSTEMS
THE UNIQUETM SYSTEM – VARIAN ADDS RAPIDARC®
AND IMAGE GUIDANCE TO LOW ENERGY
TREATMENT PLATFORM FOR RADIATION THERAPY IN
INTERNATIONAL CANCER CLINICS
Figure 2
Figure 1: UNIQUE™ Linear
Accelerator – core of the
UNIQUE Solution
Figure 2: The UNIQUE™
PortalVision system for Image
Figure 1
Guided Radiotherapy (IGRT)
Figure 3: RapidArc® plan of an
S
ince Varian Medical Systems introduced its UNIQUETM NPC case treated on UNIQUE
with excellent sparing of critical
linear accelerator for international cancer clinics, the organs (data courtesy of Prince of
world’s first low-energy radiotherapy system with Wales Hospital, HongKong)
image-guidance and RapidArc treatment capabilities has made Figure 4: Accurate Head & Neck
advanced care more affordable and more widely available to Patient Setup on UNIQUE
cancer patients around the world.
The UNIQUETM system represents a complete cost- Figure 3
effective radiation oncology solution featuring all components
and services to build a state-of-the-art radiation therapy
cancer centre.
“This package is truly a unique offering for international
markets,” says Kolleen Kennedy, president of Varian’s
Oncology Systems business. “We added high-tech image-
guidance and arc therapy tools to a low energy platform
together with our treatment planning and information
management software so that technology for fast, state-of-
the-art cancer treatments can be made available to treatment
centres at a cost around US$2 million. The UNIQUETM system
is in keeping with our mission to save more lives by making
proven advanced radiotherapy technology available to people
who currently do not have access to it.”
The UNIQUETM Performance Edition incorporates all the
tools needed to easily establish or enhance a clinically
effective radiotherapy treatment operation. The UNIQUETM
platform’s low energy medical linear accelerator (Figure 1)
incorporates Varian’s proven technologies for reliable and
Figure 4
consistent dose control, delivery, and beam shaping, into an
CANCER CONTROL 2013 95